The above results indicate that glia-to-neuron conversion by PTB deleption may have a therapeutic potential for PD or other neurodegenerative diseases, even neuronal injuries such as trauma, tumor, or stroke. This evidence concerns the gene PTBP1 and Parkinson disease.